Compugen
CGEN
#8639
Rank
โ‚น22.72 B
Marketcap
โ‚น240.21
Share price
6.41%
Change (1 day)
84.24%
Change (1 year)

Revenue for Compugen (CGEN)

Revenue in 2026 (TTM): โ‚น6.52 Billion

According to Compugen's latest financial reports the company's current revenue (TTM ) is โ‚น7.00 Billion. In 2025 the company made a revenue of โ‚น6.53 Billion an increase over the revenue in the year 2024 that were of โ‚น2.39 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Compugen from 2000 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚น6.52 B-0.13%
2025 โ‚น6.53 B173.26%
2024 โ‚น2.39 B-14.18%
2023 โ‚น2.78 B348.81%
2022 โ‚น0.62 B38.97%
2021 โ‚น0.44 B205.32%
2020 โ‚น0.14 B
2019 N/A-100%
2018 โ‚น1.24 B
2017 N/A-100%
2016 โ‚น48.38 M-92.15%
2015 โ‚น0.61 B-21.34%
2014 โ‚น0.78 B257.48%
2013 โ‚น0.21 B1554.74%
2012 โ‚น13.25 M
2011 N/A-100%
2010 โ‚น49.96 M330.72%
2009 โ‚น11.6 M-28.6%
2008 โ‚น16.24 M
2004 โ‚น0.17 B-56.6%
2003 โ‚น0.40 B-24.49%
2002 โ‚น0.53 B-2.92%
2001 โ‚น0.54 B61.79%
2000 โ‚น0.33 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Seagen
SGEN
โ‚น221.91 B 3,066.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
โ‚น1.64 B-76.46%๐Ÿ‡ฆ๐Ÿ‡บ Australia
Teva Pharmaceutical Industries
TEVA
โ‚น1.673 T 23,776.90%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Eterna Therapeutics
ERNA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA